Vnitr Lek 2013, 59(8):689-693

Biliary (cholestatic) complications in the liver graft biopsy samples early after transplantation

E. Honsová
Pracoviště klinické a transplantační patologie, Transplantcentrum IKEM Praha, vedoucí pracoviště prim. MUDr. Eva Honsová, Ph.D.

During the first three months after a liver transplant, cholestasis of various type and degree represents 1 of the most frequent morphological findings in liver graft biopsies. The morphology of cholestasis is typical for all conditions with bile duct impairment but also for other conditions with more severe impairment of hepatocytes, including rejection and recurrence of viral hepatitides. Histological diagnosis represents the gold standard in addressing liver graft dysfunction causes, and in the majority of cases it allows for distinguishing between the main categories of diseases resulting in cholestasis. Usually a combination of various changes can be identified as a cause of the liver graft dysfunction early after transplantation. Therefore, the interpretation of limited morphological characteristics, which usually represent a certain type of tissue reaction, not the cause, is complicated. The close cooperation between the hepatologist and pathologist has become a necessary prerequisite for the best possible interpretation of the morphological conclusion.

Keywords: liver transplant; cholestasis; biliary complications

Received: May 15, 2013; Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Honsová E. Biliary (cholestatic) complications in the liver graft biopsy samples early after transplantation. Vnitr Lek. 2013;59(8):689-693.
Download citation

References

  1. Zhai Y, Busuttil RW, Kupiec-Weglinski JV. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 2011; 11: 1563-1569. Go to original source... Go to PubMed...
  2. Hübscher S. Antibody-mediated rejection in the liver allograft. Curr Opin Organ Transplant 2012; 17: 280-286. Go to original source... Go to PubMed...
  3. Kusumoto S, Tanaka Y, Mizokami M et al. Reactivation of hepatitis B virus following systemic chemotherapy for malignit lymphoma. Int J Hematol 2009; 90: 13-23. Go to original source... Go to PubMed...
  4. Honsová E, Sperl J. Fibrocholestatická hepatitida, onemocnění nejen transplantovaných pacientů. Cesk Patol 2011; 47: 55-58. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.